Amrize Insider Buying Offers Rare Bright Spot as Shares Languish Near Lows
Published on 08/28/2026 at 20:03 | Editorial boerse-global.de
Samuel J. Poletti has put his money where his new job is. Just days before being elevated to chief financial officer at Amrize, the executive purchased 2,510 company shares at an average price of $46.92 — a level well above where the stock currently trades. The transaction, disclosed in a mandatory SEC filing, has since been interpreted by market participants as a vote of confidence from a manager stepping into one of the most scrutinized roles at the building-materials group.
Poletti's buy was not an isolated gesture. Stephen S. Clark, the chief people officer, and Jaime Hill, president of building materials, also acquired shares in recent weeks at prices around $47, according to separate SEC filings. Insider purchases at depressed valuations are often read by analysts as a signal that management sees the sell-off as overdone, even if such trades carry no short-term guarantees.
The board named Poletti CFO on Monday with immediate effect, promoting him from his previous position as chief strategy and M&A officer. He succeeds Baris Oran, who is leaving the company for personal reasons. In a parallel move, Dillon Cumming was appointed vice president of investor relations, a role that takes on added significance given the widening gap between Amrize's operational performance and its market valuation.
That disconnect is stark. The shares are down roughly 18 percent since the start of the year and recently touched a 52-week low of €37.50. Friday's session brought some relief, with the stock climbing 1.9 percent to €38.72 in European trading — still just 3.3 percent above that trough and about 31 percent below February's high. The technical picture remains fragile: the equity sits 10 percent under its 50-day moving average and 16 percent below the 200-day line, pointing to a firmly established downtrend. Monthly volatility of 38 percent on an annualized basis underscores the nervousness among holders.
Should investors sell immediately? Or is it worth buying Amrize?
The catalyst for the recent slide was twofold. Disappointing margin data rattled investors, and the abrupt finance-chief transition added a layer of uncertainty. In Swiss trading, the stock initially sank to CHF 35.10 before finding a foothold around CHF 35.90.
Yet the operational numbers tell a more encouraging story. Second-quarter revenue rose 8.6 percent to $3.494 billion, while net income climbed 14.4 percent to $476 million. For the first half, Amrize booked sales of $3.95 billion, up 10 percent year on year, with earnings per share of $0.86. Management has guided to full-year 2026 revenue of up to $12.7 billion, having lifted its forecast to a range of $12.5 billion to $12.7 billion after the second-quarter beat. The company also paid its quarterly dividend of $0.11 per share to shareholders on record as of the same day.
The acquisition of Rapid Redi-Mix, a Texas-based ready-mix concrete supplier announced in July, forms part of the broader growth strategy that Amrize has pursued since its spin-off from Holcim. That deal, aimed at deepening the company's regional footprint in the US building-materials market, predates the recent management shuffle and is not tied to it.
Whether the fresh faces in the finance and investor-relations functions can help close the perception gap remains an open question. Poletti, for his part, arrives with deep institutional knowledge from his strategy and M&A tenure — and a personal stake in the outcome that now sits meaningfully underwater.
Ad
Amrize Stock: New Analysis - 28 August
Fresh Amrize information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
